Annual total expenses:
$1.10B+$92.75M(+9.24%)Summary
- As of today (September 16, 2025), RARE annual total expenses is $1.10 billion, with the most recent change of +$92.75 million (+9.24%) on December 31, 2024.
- During the last 3 years, RARE annual total expenses has risen by +$363.06 million (+49.52%).
- RARE annual total expenses is now at all-time high.
Performance
RARE Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$281.45M-$8.93M(-3.07%)Summary
- As of today (September 16, 2025), RARE quarterly total expenses is $281.45 million, with the most recent change of -$8.93 million (-3.07%) on June 30, 2025.
- Over the past year, RARE quarterly total expenses has increased by +$2.82 million (+1.01%).
- RARE quarterly total expenses is now -16.19% below its all-time high of $335.81 million, reached on September 30, 2022.
Performance
RARE Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
RARE Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.2% | +1.0% |
| 3 y3 years | +49.5% | +13.7% |
| 5 y5 years | +107.7% | +673.3% |
RARE Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.5% | -16.2% | +13.7% |
| 5 y | 5-year | at high | +107.7% | -16.2% | +673.3% |
| alltime | all time | at high | >+9999.0% | -16.2% | +1537.7% |
RARE Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $281.45M(-3.1%) |
| Mar 2025 | - | $290.37M(-2.6%) |
| Dec 2024 | $1.10B(+9.2%) | $298.26M(+9.2%) |
| Sep 2024 | - | $273.01M(-2.0%) |
| Jun 2024 | - | $278.62M(-0.3%) |
| Mar 2024 | - | $279.52M(+11.5%) |
| Dec 2023 | $1.00B(-0.9%) | $250.58M(-2.8%) |
| Sep 2023 | - | $257.70M(-3.9%) |
| Jun 2023 | - | $268.14M(+1.4%) |
| Mar 2023 | - | $264.47M(+3.6%) |
| Dec 2022 | $1.01B(+38.1%) | $255.18M(-24.0%) |
| Sep 2022 | - | $335.81M(+35.7%) |
| Jun 2022 | - | $247.50M(+6.6%) |
| Mar 2022 | - | $232.25M(+12.8%) |
| Dec 2021 | $733.14M(+22.0%) | $205.85M(+33.1%) |
| Sep 2021 | - | $154.65M(-26.1%) |
| Jun 2021 | - | $209.40M(-11.1%) |
| Mar 2021 | - | $235.54M(+103.8%) |
| Dec 2020 | $601.15M(+13.9%) | $115.55M(-23.1%) |
| Sep 2020 | - | $150.31M(+313.0%) |
| Jun 2020 | - | $36.39M(-76.6%) |
| Mar 2020 | - | $155.33M(+20.0%) |
| Dec 2019 | $527.89M(+24.8%) | $129.40M(-6.8%) |
| Sep 2019 | - | $138.79M(+12.5%) |
| Jun 2019 | - | $123.32M(+7.3%) |
| Mar 2019 | - | $114.93M(+10.4%) |
| Dec 2018 | $422.87M | $104.09M(+5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $99.07M(+51.2%) |
| Jun 2018 | - | $65.52M(-434.7%) |
| Mar 2018 | - | -$19.58M(-123.3%) |
| Dec 2017 | $331.55M(+33.6%) | $84.14M(+5.9%) |
| Sep 2017 | - | $79.42M(+9.0%) |
| Jun 2017 | - | $72.89M(+6.7%) |
| Mar 2017 | - | $68.29M(-4.2%) |
| Dec 2016 | $248.14M(+68.0%) | $71.29M(+9.6%) |
| Sep 2016 | - | $65.02M(+14.2%) |
| Jun 2016 | - | $56.94M(+7.9%) |
| Mar 2016 | - | $52.76M(-4.5%) |
| Dec 2015 | $147.74M(+160.2%) | $55.22M(+40.8%) |
| Sep 2015 | - | $39.23M(+31.7%) |
| Jun 2015 | - | $29.79M(+39.3%) |
| Mar 2015 | - | $21.38M(+27.7%) |
| Dec 2014 | $56.78M(+75.9%) | $16.74M(+5.6%) |
| Sep 2014 | - | $15.85M(+16.7%) |
| Jun 2014 | - | $13.59M(-0.3%) |
| Mar 2014 | - | $13.63M(+20.4%) |
| Dec 2013 | $32.28M(+101.9%) | $11.32M(-10.1%) |
| Sep 2013 | - | $12.59M(>+9900.0%) |
| Jun 2013 | - | $0.00(-100.0%) |
| Mar 2013 | - | $6.74M(-1.1%) |
| Dec 2012 | $15.98M(+143.6%) | $6.81M(+28.5%) |
| Sep 2012 | - | $5.30M(>+9900.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00 |
| Dec 2011 | $6.56M | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual total expenses?
- What is the all time high annual total expenses for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual total expenses year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly total expenses?
- What is the all time high quarterly total expenses for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly total expenses year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual total expenses?
The current annual total expenses of RARE is $1.10B
What is the all time high annual total expenses for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual total expenses is $1.10B
What is Ultragenyx Pharmaceutical Inc. annual total expenses year-on-year change?
Over the past year, RARE annual total expenses has changed by +$92.75M (+9.24%)
What is Ultragenyx Pharmaceutical Inc. quarterly total expenses?
The current quarterly total expenses of RARE is $281.45M
What is the all time high quarterly total expenses for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly total expenses is $335.81M
What is Ultragenyx Pharmaceutical Inc. quarterly total expenses year-on-year change?
Over the past year, RARE quarterly total expenses has changed by +$2.82M (+1.01%)